HealthUS FDA approves Revolution Medicines targeted drug for metastatic pancreatic cancer
The US Food and Drug Administration has approved a targeted drug from Revolution Medicines for adults with metastatic pancreatic cancer who have received prior treatment or cannot undergo combination chemotherapy.
US FDA approves Revolution Medicines targeted drug for metastatic pancreatic cancer
